Edwards Lifesciences Corp Quarterly Debt-to-equity in % from Q2 2022 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Edwards Lifesciences Corp quarterly Debt-to-equity history and growth rate from Q2 2022 to Q2 2025.
  • Edwards Lifesciences Corp Debt-to-equity for the quarter ending June 30, 2025 was 30 %, a 19.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 30 -7.44 -19.9% Jun 30, 2025
Q1 2025 31.7 -7.05 -18.2% Mar 31, 2025
Q4 2024 33.7 -6.95 -17.1% Dec 31, 2024
Q3 2024 36.3 -5.15 -12.4% Sep 30, 2024
Q2 2024 37.4 -3.8 -9.22% Jun 30, 2024
Q1 2024 38.8 -2.88 -6.91% Mar 31, 2024
Q4 2023 40.7 -1.18 -2.82% Dec 31, 2023
Q3 2023 41.4 -1.14 -2.68% Sep 30, 2023
Q2 2023 41.2 -3.41 -7.64% Jun 30, 2023
Q1 2023 41.7 Mar 31, 2023
Q4 2022 41.8 Dec 31, 2022
Q3 2022 42.5 Sep 30, 2022
Q2 2022 44.6 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.